Amyloid ␤ protein (A␤) 
Introduction
Alzheimer's disease (AD) belongs to a large cohort of diseases characterized by amyloidoses. Extracellular senile plaques, the foremost pathophysiological hallmark of AD are composed of a dense core of amyloid fibrils associated with degenerating neurites, astrocytes and astrocytic processes [1] . Amyloid ␤ protein (A␤) is the main protein component of senile plaques [2] . Extracellular A␤ is generated by proteolytic processing of amyloid precursor protein (APP) by ␤-secretase followed by ␥-secretase at the cell surface. In the AD brain, there appears to be an apparent failure in regulating the production and clearance of A␤, leading to increased levels of A␤ and consequently aggregation and neurotoxicity ( Fig. 1) . Studies using mouse models, cell culture, synthetic A␤ and biophysical methods have shown a strong correlation between increased levels of A␤ leading to acute dementia in AD [3] [4] [5] [6] [7] [8] [9] [10] . Due to A␤'s ability to bind several different molecules and attain multiple physical states [11] , our understanding of the key neurotoxic mechanism(s) causing cognitive decline in AD is incomplete. It is also increasingly believed that cognitive decline in AD is a result of multiple toxicity mechanisms of different A␤ forms.
The onset of AD supports an age-dependent dichotomous model including familial early onset cases (10% of all AD cases) and late onset cases. Increased production of A␤ is a feature of early onset AD and can be caused by mutations observed in APP
and ␥-secretase complex [12] . Three 
Mechanism of amyloid aggregation
Fibril formation is considered to be an aggregation pathway originating from a high entropic barrier and a thermodynamically unfavourable event [29] . The aggregation of A␤ is initiated by a conformational change from random coil or ␣-helix into a ␤-strand, quite similar to prion diseases. Hydrophobic interactions are eventually maximized by ␤-sheet conformation [29, 30] . A␤ aggregation and fibril formation are nucleation dependent and the kinetics of fibril formation are determined by nucleation and fibril elongation rate [31] . Although, the formation of nuclei is thermodynamically unfavourable, the addition of monomeric molecules to the existing nuclei is favourable, and occurs by perpendicular hydrogen bonding to the axis of the amyloid nucleus [11] .
A considerable number of environmental factors as well as some intrinsic properties of proteins can work in concert to cause amyloidogenesis (Fig. 1) 
A␤: a natively unfolded protein?
The folding of proteins into their correct three-dimensional structure is critically important for their biological activity and normal functioning of the cell. With the human proteome reaching a size of more than 100,000 proteins, it is clearly evident that protein folding occurs in a crowded and sensitive environment highly prone to aggregation [26] . However, cellular systems have evolved to evade unfavourable protein aggregation. Negative selection has been observed to avoid alternating polar and hydrophobic residues that favour a ␤-sheet structure [56] . It is also suggested that residues showing increased vulnerability to aggregation are preferably located in different regions of the sequence from those that determine native protein folding, termed 'kinetic partitioning' [57] . Apart from amino acid sequence selection, biological systems have developed molecular chaperones and degradation mechanisms to control the rate of formation of unfavourable structures [58] . Proteins are required to possess fast folding kinetics and high stability to minimize the risk of protein aggregation in the cell [69] . But certain proteins may require higher-order structural disorders mediated by binding to ligands to fulfil their function [70, 71] . Such proteins have greater structural plasticity to favour ligand binding and could be classified under the emerging class of 'natively unfolded proteins' [72] . The presence of natively unfolded proteins in the cell is believed to provide a simple solution to having large intermolecular interfaces for diverse ligand binding and regulation, and smaller protein, genome and cell sizes [73] . There is an increasing belief that amyloidogenic proteins could be natively unfolded proteins [74] . A␤ is known to bind a large array of extracellular and cell-associated ligands (Table 3 , Fig. 1 [106, 107] . Apart from the propensity of A␤42 to generate multiple conformations, it possesses oxidative [113] , hydrolytic [114] , and surfactant properties [115] . It is also clear that different A␤ assemblies can possess distinct toxicity mechanisms [116] in different cell lines, even in yeast [111] .
Formation of amyloid plaques
A␤ deposits in the brain are usually referred to as senile plaques. A␤ plaques can also be observed in cognitively normal individuals [117] [118] [119] . The major variation between A␤ deposits in normal individuals and those found in AD patients is their distribution [118] . In Arctic (E22G) [61] Increased rate of fibril formation [62] Dutch (E22Q) [63] Causes higher amount of apoptosis at physiological concentrations with 24 h incubation, faster aggregation than wild-type, increased rate of fibril formation [60, 62] Italian (E22K) [64] Aggregates rapidly [65] Iowa (D23N) [66] Aggregates rapidly [65] Pyroglutamate-modified A␤N3(pE) [67] A␤N3(pE)-40/42 peptides shows resistance to degradation by cultured astrocytes [68] addition
to A␤, other proteins accumulate within senile plaques, including apolipoprotein E (apoE), ␣2-macroglobulin, interleukins, components of the complement system, ␣2-macroglobulin receptor, low-density lipoprotein receptor-related protein, collagenous
Alzheimer amyloid component [120] [121] [122] [123] [124] and also dystrophic neurites, reactive astrocytes, and microglial cells [121, 125] . [127, 128] which precedes formation of amyloid plaques in the brain [129] . Intracellular A␤ has been postulated to originate from the result of intracellularly localized APP proteolysis [130] [131] [132] or by receptor associated uptake of extracellularly secreted A␤ [133] [134] [135] [136] [137] . As the majority of A␤ is secreted, it is suggested that APP proteolysis predominantly occurs at the cell membrane or cleaved A␤ is rapidly secreted [126] . Previous studies also have shown that intraneuronal A␤ is observed only in transgenic models based on APP overexpression [138, 139] [140] . However, the nature of intracellular A␤ assembly, mechanism of action and its relevance to AD pathology needs to be addressed. [141, 142] . Depleted neurotransmitters [142] , 25 to 35% decrease in the synapses [143, 144] Formyl peptide receptor-like 1 [86] Amyloid precursor protein [87] 
Apart from extracellular accumulation, A␤ is also known to form insoluble pools intracellularly (reviewed in [126]). Recent studies have confirmed the build up of intracellular A␤ in neuronal cells as an early event in AD pathogenesis

and not in wild-type. Thus it seems like that the origin of intracellular A␤ is largely by uptake from extracellular media. Intracellular A␤ is also implicated in synaptic dysfunction and associated cognitive decline
Role of A␤ in AD pathogenesis
Memory impairment including the loss of the ability to form and retain new episodic memories is the hallmark of early stages of AD. Cognitive impairment is often attributed to synaptic dysfunction and neuronal cell loss particularly in the cells interconnecting the hippocampal formation with the associating structures crucial for memory
and quantitative correlations of postmortem cytopathology with cognitive deficits indicate that
Scavenger receptors SR-A, SR-BI [17]
␣7nicotinic acetylcholine receptor (␣7nAChR) [88] CD47, CD36, ␣6␤1-integrin [89] Serpin-enzyme complex receptor (SEC-R) [90] Integrin ␤1 [91] HSP [92] Intracellular proteins:
A␤ binding alcohol dehydrogenase [93] Chaperone proteins [94] 20S proteasome [95] Extracellular matrix proteins: 
Others:
Membrane lipids [100] Chondroitin sulphate-derived Monosaccharides and Disaccharides [101] Cholesterol [102] 
A␤ isoform
Soluble dimers [108] , tetramers and oligomers [2] Non-amyloidogenic amorphous aggregates [109] Amyloidogenic fibrils [109] Fibrillar aggregates [50] Amyloid proto-fibrils [31] Amyloid derived diffusible ligands [110] Soluble non-fibrillar [111] Hexamer, nonamer, dodecamer, A␤*56 (56-kD soluble A␤ assembly) [112] synaptic loss is more robustly correlated than the numbers of plaques or tangles, or extent of cortical gliosis [145] . Lesne et al. [112] 
